Radiofrequency Treatment for Skin Conditions
Trial Summary
What is the purpose of this trial?
This research is being done to assess the effect of radiofrequency (RF)-based treatment on skin and skin conditions.
Will I have to stop taking my current medications?
The trial requires that participants not be on certain medications, such as systemic steroids, immune modulators, blood thinners, and medications that may impair wound healing. If you are taking these, you may need to stop them to participate.
What data supports the effectiveness of the radiofrequency treatment for skin conditions?
Is radiofrequency treatment safe for skin conditions?
How is radiofrequency treatment different from other treatments for skin conditions?
Radiofrequency treatment is unique because it uses energy to heat the deeper layers of the skin, promoting collagen remodeling and skin tightening without surgery or significant recovery time. This non-invasive approach is effective for both cosmetic and noncosmetic skin conditions, offering a safer alternative to more invasive procedures.12489
Eligibility Criteria
This trial is for adults aged 22-70 with mild to moderate Hidradenitis Suppurativa (HS) localized to the underarms, or healthy individuals. Participants must understand the study and follow procedures, including multiple skin biopsies. Excluded are those on certain medications like blood thinners, immune modulators, systemic steroids; with allergies to anesthetics; active infections; significant medical history; pregnant/nursing women; or a history of severe scarring.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive up to 3 treatments of RF-based selective electrothermolysis to pre-selected areas of the axillary skin
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Radiofrequency-Based treatment (Radiofrequency-Based treatment)
Radiofrequency-Based treatment is already approved in European Union, United States, Canada, Japan for the following indications:
- Skin rejuvenation
- Wrinkle reduction
- Acne treatment
- Body contouring
- Facial skin tightening
- Skin rejuvenation
- Acne treatment
- Body contouring
- Skin rejuvenation
- Wrinkle reduction
- Acne treatment
- Skin laxity
- Facial skin tightening
- Acne treatment